InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Anders Bladh. Director active across 1 company, notably XSpray Pharma AB (publ). Cumulatively, 4 reports have been recorded. History available since 3 June 2026. The latest transaction was disclosed on 3 June 2026 (Sale). Regulator: FIN-FSA. All data is openly available.
4 of 4 declarations